FDA Inspection 618483 — Triax Pharmaceuticals, LLC

Triax Pharmaceuticals, LLC — FEI 3005130594

The FDA completed an inspection of Triax Pharmaceuticals, LLC on Oct 5, 2009 in Cranford, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 5, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cranford, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.